News | Vena Cava Filters

September 26, 2017 — The one-year results of the SENTRY clinical trial were presented by principal investigator Michael ...

Home September 26, 2017
Home
News | Cardio-oncology

Treatment of heart attack patients depends on their history of cancer, according to research published recently in European Heart Journal: Acute Cardiovascular Care. The study in more than 35,000 heart attack patients found they were less likely to receive recommended drugs and interventions, and more likely to die in hospital if they had cancer than if they did not.

Home September 26, 2017
Home
News | Heart Failure

BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure Trial was presented during the “Heart Failure: The Big Target for CV Regenerative Therapy State of the Field” session at the Texas Heart Institute International Symposium on Cardiovascular Regenerative Medicine, Sept. 15-16 in Houston. As an invited faculty member for the meeting, Professor of Cardiovascular Medicine at the University of Florida and study co-national principal investigator Carl Pepine, M.D., presented the design.

Home September 25, 2017
Home
News | Stents Bare Metal

Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce restenosis rates, according to results from various Biotronik studies. The results were presented at the 2017 congress of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), Sept. 16-20 in Copenhagen, Denmark.

Home September 22, 2017
Home
News | Robotic Systems

The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and the first in Canada to be exclusively dedicated to cardiac surgery. "The development of robotic cardiac surgery plays a major role in the expansion of minimally invasive surgery, whose purpose is to minimize the trauma endured by the body by reducing the incision size, for instance", according to the surgical team counting among its members Michel Pellerin, M.D., and Denis Bouchard, M.D., the two cardiac surgeons who performed the first robotic mitral intervention last April. "This new technology will improve the patients' quality of life and allow for a faster return to daily activity, among other benefits", they continued.

Home September 22, 2017
Home
Technology | Implantable Cardioverter Defibrillator (ICD)

Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for one of the company's most widely-used implantable cardioverter defibrillators (ICD) and associated high voltage leads. The approval of MR-conditional labeling for the Ellipse ICD with the Tendril MRI pacing lead and Durata and Optisure high voltage leads adds another patient-centric benefit to the device and will help further improve access for patients suffering from abnormally fast heart rhythms who need an ICD and who may need an MRI scan in the future.

Home September 22, 2017
Home
News | Simulators

September 21, 2017 — Fujitsu announced that the University of Tokyo recently used heart simulator viewers with ...

Home September 21, 2017
Home
News | Heart Valve Technology

Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia aortic valve, the first in a new class of resilient heart valves.

Home September 21, 2017
Home
News | Heart Failure

MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study were presented at the Heart Failure Society of America (HFSA) 21st Annual Scientific Meeting, Sept. 16-19 in Dallas. PIONEER-HCM was a study of mavacamten in symptomatic, obstructive hypertrophic cardiomyopathy (oHCM) patients.

Home September 21, 2017
Home
News | Magnetic Resonance Imaging (MRI)

September 21, 2017 — Toshiba Medical will highlight its latest magnetic resonance imaging (MRI) technology, led by the ...

Home September 21, 2017
Home
News | Stents Bifurcation

September 21, 2017 — Cardinal Health and Tryton Medical Inc. announced that the Tryton coronary Side Branch Stent was ...

Home September 21, 2017
Home
News | Peripheral Artery Disease (PAD)

September 20, 2017 — Not-for-profit preclinical research institute CBSET announced that its scientists have published ...

Home September 20, 2017
Home
News | Ultrasound Intra-cardiac Echo (ICE)

September 20, 2017 — Catheter ablation to treat an irregular heartbeat, which limits or eliminates patients’ exposure to ...

Home September 20, 2017
Home
News | Peripheral Artery Disease (PAD)

Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress, Sept. 16-20 in Copenhagen, Denmark.

Home September 20, 2017
Home
News | Cardiovascular Information Systems (CVIS)

ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of Nuclear Cardiology’s (ASNC) 22nd Annual Scientific Session, Sept. 14-17 in Kansas City, Mo. ScImage, provider of scalable web-based image and information management systems, has teamed with Invia, a cardiology imaging software solutions provider, to enable users of ScImage’s Picom365 Enterprise PACS (picture archiving and communication system) seamless access to 4DM. Users of Picom365 will now have access to 4DM’s advanced quantification capabilities as part of their on-premises, cloud or hybrid enterprise solution.

Home September 19, 2017
Home
Subscribe Now